approved

Приложение 4 на ПЛС от 02.10.2019 г.

Unique identificator:  3a71363a-93ef-4673-a381-3b0cfaf07b86

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2019-10-03 09:13:02
  • Created by: georgi_sivchev
  • Updated at: 2019-10-03 09:13:02
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Didanosine II-0684/27.09.2007 VIDEX EC, Gastro resistant capsule, hard, 400, mg, Pack: 30 Bristol-Myers Squibb Kft, Унгария Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, F19250 Meymac, France 232.47 46.49 278.96 4% 9.3 241.77 48.35 290.12 16% 25 266.77 53.35 320.12 КЦРР-1000/23.07.2012 07.08.2012 07.08.2012 Неактивен 1291
Didanosine II-0681/27.09.2007 VIDEX EC, Gastro resistant capsule, hard, 250, mg, Pack: 30 Bristol-Myers Squibb Kft, Унгария Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, F19250 Meymac, France 145.3 29.06 174.36 4% 5.81 151.11 30.22 181.33 16% 23.25 174.36 34.87 209.23 КЦРР-1000/23.07.2012; НСР-9746/14.07.2016 07.08.2012 02.08.2016 Заличен 1290
Didanosine II-0681/27.09.2007 VIDEX EC, Gastro resistant capsule, hard, 250, mg, Pack: 30 Bristol-Myers Squibb Kft, Унгария Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, F19250 Meymac, France 145.3 29.06 174.36 4% 5.81 151.11 30.22 181.33 16% 23.25 174.36 34.87 209.23 КЦРР-1000/23.07.2012 07.08.2012 07.08.2012 Неактивен 1290
Didanosine II-0684/27.09.2007 VIDEX EC, Gastro resistant capsule, hard, 400, mg, Pack: 30 Bristol-Myers Squibb Kft, Унгария Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, F19250 Meymac, France 301.94 60.39 362.33 6% 15 316.94 63.39 380.33 18% 30 346.94 69.39 416.33 КЦ-682/06.03.2009 23.03.2009 23.03.2009 Неактивен 1291
Didanosine II-0681/27.09.2007 VIDEX EC, Gastro resistant capsule, hard, 250, mg, Pack: 30 Bristol-Myers Squibb Kft, Унгария Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, F19250 Meymac, France 188.7 37.74 226.44 6% 11.32 200.02 40 240.02 18% 30 230.02 46 276.02 КЦ-682/06.03.2009 23.03.2009 23.03.2009 Неактивен 1290
Ombitasvir, paritaprevir and ritonavir EU/1/14/982/001 Viekirax, Film coated tablet, 12,5 mg/75 mg/50 mg, mg, Pack: 56 AbbVie Deutschland GmbH & Co. KG, Германия AbbVie Deutschland GmbH & Co. KG, Knollstrasse 67061 Ludwigshafen, Германия 16598.66 3319.73 19918.39 4% 10 16608.66 3321.73 19930.39 16% 25 16633.66 3326.73 19960.39 корекционно решение НСР-7662/01.12.2015; Промяна на обстоятелствата НСР-16390/02.08.2018 НСР-7449/10.11.2015. (предварително изпълнение); НСР-9619/23.06.2016 г.; НСР-14090/06.10.2017; НСР-17550/13.12.2018 предварително изпълнение 13.12.2018 02.01.2019 Активен 4091
Ombitasvir, paritaprevir and ritonavir EU/1/14/982/001 Viekirax, Film coated tablet, 12,5 mg/75 mg/50 mg, mg, Pack: 56 AbbVie Deutschland GmbH & Co. KG, Германия AbbVie Deutschland GmbH & Co. KG, Knollstrasse 67061 Ludwigshafen, Германия 17232.13 3446.43 20678.56 4% 10 17242.13 3448.43 20690.56 16% 25 17267.13 3453.43 20720.56 корекционно решение НСР-7662/01.12.2015; Промяна на обстоятелствата НСР-16390/02.08.2018 НСР-7449/10.11.2015. (предварително изпълнение); НСР-9619/23.06.2016 г.; НСР-14090/06.10.2017 21.10.2017 02.09.2018 Неактивен 4091
Ombitasvir, paritaprevir and ritonavir EU/1/14/982/001 Viekirax, Film coated tablet, 12,5 mg/75 mg/50 mg, mg, Pack: 56 AbbVie Ltd, Обединено Кралство AbbVie Deutschland GmbH & Co. KG, Knollstrasse 67061 Ludwigshafen, Германия 17232.13 3446.43 20678.56 4% 10 17242.13 3448.43 20690.56 16% 25 17267.13 3453.43 20720.56 корекционно решение НСР-7662/01.12.2015 НСР-7449/10.11.2015. (предварително изпълнение); НСР-9619/23.06.2016 г.; НСР-14090/06.10.2017 21.10.2017 02.11.2017 Неактивен 4091
Ombitasvir, paritaprevir and ritonavir EU/1/14/982/001 Viekirax, Film coated tablet, 12,5 mg/75 mg/50 mg, mg, Pack: 56 AbbVie Ltd, Обединено Кралство AbbVie Deutschland GmbH & Co. KG, Knollstrasse 67061 Ludwigshafen, Германия 23451.01 4690.2 28141.21 4% 10 23461.01 4692.2 28153.21 16% 25 23486.01 4697.2 28183.21 корекционно решение НСР-7662/01.12.2015 НСР-7449/10.11.2015. (предварително изпълнение); НСР-9619/23.06.2016 г. 02.08.2016 02.08.2016 Неактивен 4091
Ombitasvir, paritaprevir and ritonavir EU/1/14/982/001 Viekirax, Film coated tablet, 12,5 mg/ 75 mg/ 50 mg, mg, Pack: 56 AbbVie Ltd, Обединено Кралство AbbVie Deutschland GmbH & Co. KG, Knollstrasse 67061 Ludwigshafen, Германия 25191.09 5038.22 30229.31 4% 10 25201.09 5040.22 30241.31 16% 25 25226.09 5045.22 30271.31 корекционно решение НСР-7662/01.12.2015 НСР-7449/10.11.2015. (предварително изпълнение) 10.11.2015 10.11.2015 Неактивен 4091
Cholecalciferol № II-10950/01.06.2005 VIGANTOL OIL, -, 0, 5 mg/ml - 10 ml, mg, Pack: 1 Merck KGaA, Германия Merck K GaA - Germany 1.9 0.38 2.28 7% 0.13 2.03 0.41 2.44 20% 0.38 2.41 0.48 2.89 цената се заличава КЦРР-1519/25.10.2012 КЦ-1944/25.01.2011 17.02.2011 17.02.2011 Заличен 1012
Vildagliptin, Metformin 20170219 VILSPOX, Film coated tablet, 50 mg/1000 mg, mg, Pack: 30 (PA/Alu/PVC/Alu) Sandoz d.d., Словения Lek Pharmaceuticals d.d., Словения; Novartis Pharma GmbH, Германия; Salutas Pharma GmbH, Германия 16.84 3.37 20.21 6% 1.01 17.85 3.57 21.42 18% 3.03 20.88 4.18 25.06 НСР-15273/16.03.2018 Предварително изпълнение 16.03.2018 02.04.2018 Активен 16053
Vildagliptin, Metformin 20170218 VILSPOX, Film coated tablet, 50 mg/850 mg, mg, Pack: 30 (PA/Alu/PVC/Alu) Sandoz d.d., Словения Lek Pharmaceuticals d.d., Словения; Novartis Pharma GmbH, Германия; Salutas Pharma GmbH, Германия 22.92 4.58 27.5 6% 1.38 24.3 4.86 29.16 18% 4.13 28.43 5.69 34.12 НСР-15273/16.03.2018 Предварително изпълнение 16.03.2018 02.04.2018 Активен 16054
elosulfase alfa EU/1/14/914/001 Vimizim, Concentrate for solution for infusion, 1 mg/ml - 5 ml, mg, Pack: 1 BioMarin International Limited, Ирландия BioMarin Pharmaceutical, Inc., САЩ; BioMarin International Limited, Ирландия 1466.87 293.37 1760.24 4% 10 1476.87 295.37 1772.24 16% 25 1501.87 300.37 1802.24 НСР-19900/30.09.2019 - Предварително изпълнение 02.10.2019 02.10.2019 Активен 15871
Lacosamide EU/1/08/470/008 VIMPAT, Film coated tablet, 150, mg, Pack: 56 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 176.69 35.34 212.03 4% 7.07 183.76 36.75 220.51 16% 25 208.76 41.75 250.51 НСР-8225/22.02.2016; НСР-10760/27.10.2016; НСР-17735/17.01.2019 01.02.2019 02.02.2019 Активен 3398
Lacosamide EU/1/08/470/008 VIMPAT, Film coated tablet, 150, mg, Pack: 56 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 179.66 35.93 215.59 4% 7.19 186.85 37.37 224.22 16% 25 211.85 42.37 254.22 НСР-8225/22.02.2016; НСР-10760/27.10.2016 11.11.2016 02.12.2016 Неактивен 3398
Lacosamide EU/1/08/470/011 VIMPAT, Film coated tablet, 200, mg, Pack: 56 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 235.58 47.12 282.7 4% 9.42 245 49 294 16% 25 270 54 324 НСР-8224/22.02.2016; НСР-10761/27.10.2016; НСР-17733/17.01.2019 01.02.2019 02.02.2019 Активен 3399
Lacosamide EU/1/08/470/011 VIMPAT, Film coated tablet, 200, mg, Pack: 56 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 239.65 47.93 287.58 4% 9.59 249.24 49.85 299.09 16% 25 274.24 54.85 329.09 НСР-8224/22.02.2016; НСР-10761/27.10.2016 11.11.2016 02.12.2016 Неактивен 3399
Lacosamide EU/1/08/470/005 VIMPAT, Film coated tablet, 100, mg, Pack: 56 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 118.95 23.79 142.74 4% 4.76 123.71 24.74 148.45 16% 19.03 142.74 28.55 171.29 НСР-8226/22.02.2016; НСР-10759/27.10.2016; НСР-14967/01.02.2018; НСР-16816/20.09.2018 05.10.2018 02.11.2018 Активен 3397
Lacosamide EU/1/08/470/005 VIMPAT, Film coated tablet, 100, mg, Pack: 56 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 119.89 23.98 143.87 4% 4.8 124.69 24.94 149.63 16% 19.18 143.87 28.77 172.64 НСР-8226/22.02.2016; НСР-10759/27.10.2016; НСР-14967/01.02.2018 16.02.2018 02.03.2018 Неактивен 3397
Lacosamide EU/1/08/470/005 VIMPAT, Film coated tablet, 100, mg, Pack: 56 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 119.91 23.98 143.89 4% 4.8 124.71 24.94 149.65 16% 19.19 143.9 28.78 172.68 НСР-8226/22.02.2016; НСР-10759/27.10.2016 11.11.2016 02.12.2016 Неактивен 3397
Lacosamide EU/1/08/470/011 VIMPAT, Film coated tablet, 200, mg, Pack: 56 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 240.02 48 288.02 4% 9.6 249.62 49.92 299.54 16% 25 274.62 54.92 329.54 НСР-8224/22.02.2016 09.03.2016 09.03.2016 Неактивен 3399
Lacosamide EU/1/08/470/008 VIMPAT, Film coated tablet, 150, mg, Pack: 56 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 179.92 35.98 215.9 4% 7.2 187.12 37.42 224.54 16% 25 212.12 42.42 254.54 НСР-8225/22.02.2016 09.03.2016 09.03.2016 Неактивен 3398
Lacosamide EU/1/08/470/005 VIMPAT, Film coated tablet, 100, mg, Pack: 56 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 120.09 24.02 144.11 4% 4.8 124.89 24.98 149.87 16% 19.21 144.1 28.82 172.92 НСР-8226/22.02.2016 09.03.2016 09.03.2016 Неактивен 3397
Lacosamide EU/1/08/470/008 VIMPAT, Film coated tablet, 150, mg, Pack: 56 UCB Pharma SA, Белгия AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium 182.3 36.46 218.76 4% 7.29 189.59 37.92 227.51 16% 25 214.59 42.92 257.51 промяна на обстоятелства НСР-8286/26.02.2016 НСР-5145/27.11.2014 11.12.2014 11.12.2014 Неактивен 3398
Showing 15101 to 15126 of 16075 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте